Found 9 matching trials
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
PHASE2Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Location
National Institutes of Health Clinical Center
SMMART Adaptive Clinical Treatment (ACT) Trial
EARLY_PHASE1SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Location
Multiple Locations
A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).
N/AA Single-Center Retrospective Study About Efficacy and Safety of Eribulin-B...
Location
Fujian Cancer Hospital
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
PHASE3This is a Phase III trial where participants will be randomized to two trea...
Location
Highlands Oncology Group
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
PHASE3This is a multicenter randomized, open label study to evaluate overall surv...
Location
Mayo Clinic-Comprehensive Cancer Center-Breast Clinic
A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer
PHASE3The purpose of this study is to compare the efficacy and safety of 9MW2821 ...
Location
Fudan University Shanghai Cancer Center
Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer
PHASE3This multicenter, open-label, randomized phase III trial is designed to stu...
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
PHASE2This study focuses on the treatment of liver metastases from three common c...
Location
Fudan University Shanghai Cancer Center
Optimal Application Timing of ADC Drugs for Advanced Breast Cancer
PHASE2This study plans to initiate a prospective, randomized controlled trial to ...
Location
Liaoning Cancer Hospital & Institute